Holders over time
- PM
- CVS
| Quarter | PM | CVS |
|---|---|---|
| Q3 2020 | 25 holders, $19.7bn | 29 holders, $8.9bn |
| Q4 2020 | 25 holders, $21.5bn | 22 holders, $9.8bn |
| Q1 2021 | 27 holders, $22.1bn | 28 holders, $10.3bn |
| Q2 2021 | 20 holders, $23.2bn | 24 holders, $11.8bn |
| Q3 2021 | 25 holders, $22.8bn | 28 holders, $11.9bn |
| Q4 2021 | 26 holders, $22.3bn | 28 holders, $14.7bn |
| Q1 2022 | 29 holders, $23.2bn | 25 holders, $14.4bn |
| Q2 2022 | 28 holders, $25.8bn | 30 holders, $13.5bn |
| Q3 2022 | 33 holders, $22.2bn | 28 holders, $13.9bn |
| Q4 2022 | 26 holders, $27.0bn | 30 holders, $12.6bn |
| Q1 2023 | 36 holders, $27.6bn | 36 holders, $9.6bn |
| Q2 2023 | 29 holders, $28.9bn | 33 holders, $9.8bn |
| Q3 2023 | 32 holders, $28.5bn | 33 holders, $11.7bn |
| Q4 2023 | 34 holders, $28.8bn | 32 holders, $14.2bn |
| Q1 2024 | 36 holders, $28.4bn | 21 holders, $14.3bn |
| Q2 2024 | 31 holders, $31.4bn | 24 holders, $14.2bn |
| Q3 2024 | 39 holders, $38.2bn | 31 holders, $14.2bn |
| Q4 2024 | 40 holders, $36.6bn | 32 holders, $11.0bn |
| Q1 2025 | 44 holders, $49.1bn | 29 holders, $19.1bn |
| Q2 2025 | 44 holders, $54.3bn | 31 holders, $19.6bn |
| Q3 2025 | 36 holders, $49.3bn | 28 holders, $21.9bn |
| Q4 2025 | 26 holders, $50.5bn | 29 holders, $22.8bn |
| Q1 2026 | 25 holders, $57.3bn | 32 holders, $21.1bn |
| Q2 2026 | 27 holders, $63.8bn | 31 holders, $30.8bn |
Philip Morris Intl Inc
- Holders
- 40
- Reported value
- $36.6bn
- Buyers
- 22
- Sellers
- 17
Breadth +5 among 94 comparable managers.
CVS Health Corp
- Holders
- 32
- Reported value
- $11.0bn
- Buyers
- 17
- Sellers
- 16
Breadth +1 among 94 comparable managers.
Who holds both, Q4 2024
Both (21)
AQR Capital Management LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), Harris Associates LP, Holocene Advisors LP, Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, Millennium Management LLC, Moore Capital Management LP, Quantbot Technologies LP, T. Rowe Price Associates Inc, Tudor Investment Corp, Two Sigma Advisers LP, Two Sigma Investments LP, Voloridge Investment Management LLC
Only PM (19)
Acadian Asset Management LLC, AllianceBernstein LP, Arrowstreet Capital LP, Artisan Partners LP, Baillie Gifford & Co, D. E. Shaw & Co., D1 Capital Partners LP, First Eagle Investment Management LLC, Lone Pine Capital LLC, Markel Group Inc, Maverick Capital Ltd, MFS Investment Management, Neuberger Berman Group LLC, Schonfeld Strategic Advisors LLC, Verition Fund Management LLC, Viking Global Investors LP, Wellington Management Group LLP, Winton Group Ltd, Woodline Partners LP
Only CVS (11)
Balyasny Asset Management LLC, Citadel Advisors LLC, Eisler Capital Management Ltd, Freestone Grove Partners LP, GAMCO Investors Inc, Glenview Capital Management LLC, Jane Street Group LLC, Marshall Wace LLP, Point72 Asset Management LP, Sachem Head Capital Management LP, Susquehanna International Group LLP
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.